Opin making life saving information easier to find

A personal story has led to the development of a more patient-centric solution that could connect participant and researcher.

“Clinical trial inefficiencies are costing billions of dollars in wasted research expenditure each year, and that is totally unacceptable and preventable,” said Michelle Gallaher, CEO of Opyl.

This is only an excerpt taken from an article originally written by Techinvest. Read the full version here.